Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
Université Paris-Sud · Institut Gustave Roussy · +9 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
807
total citations
- FWCI
- 60.64
- Percentile
- 100%
- References
- 31
Citations per year
Authors
15Topics & keywords
Topics
Keywords
- Abiraterone acetate
- Prostate cancer
- Medicine
- Prednisone
- Internal medicine
- Oncology
- Androgen deprivation therapy
- Urology
No related works found for this paper.